DOI: https://doi.org/10.22141/2224-0721.0.3.43.2019.177179

Experience of Modern Premixed Insulin Use in Treatment of Diabetes Mellitus

M.V. Vlasenko, S.V. Litvinova, N.I. Gurina, N.A. Kravchuk, Yu.O. Kryvovyaz

Abstract


No abstract


References


International Diabetes Federation. Diabetes and Cardiovascular disease: Time to Act. — Brussels, Belgium: International Diabetes Federation, 2001.

King H., Aubert R.E. & A. Herman W.H. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections // Diabetes Care. — 1998. — 1414-1431.

Niskanen L., Turpeinen A., Penttila I., Uusitupa M.I. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis // Diabetes Care. — 1998. — 21(11). —1861-1869.

Nathan D.M., Buse J.B., Davidson M.B., Heine R.J., Holman R.R., Sherwin R. et al. Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes // Diabetes Care. — 2006. — 29(8). — 1963-1972.

Дедов И.И., Шестакова М.В., Алятов А.С. и др. Проект «Консенсус совета экспертов Российской ассоциации эндокринологов (РАЭ) по инициации и интенсификации сахароснижающей терапии сахарного диабета 2 типа» // Сахарный диабет. — 2011. — № 1. — С. 95-105.

Sorkin J.D., Muller D.C., Fleg J.L., Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature // Diabetes Care. — 2005. — 28(11). — 2626-2632.

Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S. et at. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study // Diabetes Res. Clin. Pract. — 1995. — 28(2). — 103-117.

Shiraiwa T., Kaneto H., Miyatsuka T., Kato К., Yamamoto K., Kawashima A. et at. Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients // Biochem. Biophys. Res. Commun. — 2005. — 336(1). — 339-345.

Levitan E.B., Song Y., Ford E.S., Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies // Arch. Intern. Med. — 2004. — 164(19). — 2147-2155.

Hanefeld M., Cagatay M., Petrowitsch T., Neuser D., Petzinna D., Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies // Eur. Heart. J. — 2004. — 25(1). — 10-16.

Woerle H.J., Neumann C., Zschau S., Tenner S., Irsigler A., Schirra J. et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels // Diabetes. Res. Clin. Pract. — 2007.

Hanefeld M., Koehler C., Schaper F., Fuecker K., Henkel E., Temelkova-Kurktschiev T. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals // Atherosclerosis. — 1999. — 144(1). — 229-235.

Шамхалова М.Ш., Чугунова Л.А., Шестакова М.В. Цели и задачи инсулинотерапии при сахарном диабете типа 2: место готовых смесей инсулина // Consilium Medicum. — 2003. — Т. 5, № 9. — С. 491-494.

Koritkowsky M. When oral agents fail: Practical barriers to starting insulin // Int. J. Obes. Relat. Metab. Disord. — 2002. — 26 (Suppl. 3). — S18-S24.






Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2020

 

   Seo анализ сайта